Stock listing
NASDAQ:FVAM 5 01 Acquisition Corp Stock
Follow 5 01 Acquisition Corp into a list and get an email when it puts out news.
Last close · NASDAQ:FVAM
$10.00 USD
Close on Oct 26, 2022 · No longer trades
- Lowest – highest close
- $9.72 – $11.50 USDSince Oct 14, 2020 · lowest Aug 4, 2021 · highest Feb 22, 2021
Delisted NASDAQ:FVAM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:FVAM
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kush M. Parmar Other companies: Entrada Therapeutics, Inc. (Managing Partner, 5am Ventures (Board Chairman) · Since at least Oct 28, 2021); Rallybio Corporation (Director · Jul 28, 2021 – May 15, 2024 · Past); Vor Biopharma Inc. (Director · Feb 4, 2021 – Jun 14, 2022 · Past); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Arvinas, Inc. (Director · Sep 26, 2018 – Sep 24, 2019 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 15, 2022 · Past); Scpharmaceuticals Inc (Director · Nov 16, 2017 – Jun 19, 2018 · Past); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Jun 8, 2018 · Past) | Co-CEO, Director · Oct 13, 2020 – Nov 30, 2020 · Past |
| Martin Mackay Other companies: Kailera Therapeutics, Inc. (Co-Founder and Chair of Board, Rallybio Corporation · Since at least Apr 16, 2026); SpringWorks Therapeutics Inc (Director · Since at least Jul 29, 2024); Rallybio Corporation (Co-Founder and Chairman · Since at least Jul 28, 2021); Charles River Laboratories International, Inc. (Director · Since at least Jul 1, 2017); Alexion Pharmaceuticals Inc (EVP & Global Head of R&D · May 13, 2013 – Feb 27, 2017 · Past); Pfizer, Inc. (Senior Vice President · Sep 30, 2008 – May 14, 2010 · Past) | Director · Oct 13, 2020 – Oct 16, 2020 · Past |
| Andrew J Schwab Other companies: CAMP4 Therapeutics Corporation (Director · Since at least Oct 10, 2024); Skye Bioscience, Inc. (Director · Since at least Aug 18, 2023); Enliven Therapeutics, Inc. (Director · Feb 23, 2023 – Feb 23, 2023 · Past); Pear Therapeutics Inc (Director · Dec 3, 2021 – Dec 3, 2021 · Past); Flexion Therapeutics Inc (Director · Feb 11, 2014 – Mar 3, 2014 · Past) | Co-CEO, Director · Oct 13, 2020 – Nov 30, 2020 · Past |
| Daniella Beckman Other companies: Upstream Bio, Inc. (Member, Board of Directors · Since at least Oct 10, 2024); Blueprint Medicines Corp (Director · Since at least Dec 8, 2021); Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 10, 2021); Vor Biopharma Inc. (Chair of the Audit Committee · Since at least Feb 4, 2021); Translate Bio Inc (Director · Jun 18, 2019 – Sep 14, 2021 · Past) | Director · Oct 13, 2020 – Oct 16, 2020 · Past |
| Matthew R Patterson Other companies: Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 14, 2023 · Past); Audentes Therapeutics Inc (Chief Executive Officer, Director · Jul 19, 2016 – Jan 15, 2020 · Past) | Director · Oct 13, 2020 – Oct 16, 2020 · Past |
| Galya Blachman Other companies: Enliven Therapeutics, Inc. (Chief Legal Officer and Head of Business Development · Since at least Nov 5, 2026) | GC and Secretary · Oct 13, 2020 – Oct 13, 2020 · Past |
| Jason R Ruth | Chief Business Officer · Oct 13, 2020 – Oct 13, 2020 · Past |
| Rebecca L Lucia | CFO and Treasurer · Oct 13, 2020 – Oct 13, 2020 · Past |
| Samantha L Singer | Director · Nov 16, 2020 – Nov 17, 2020 · Past |
Log in to ask 6ix AI your own questions about 5 01 Acquisition Corp.